Document Type : Original Article

Authors

1 Department of Clinical Pharmacy, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran

2 Department of Pharmaceutics, Faculty of Pharmacy, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran

3 Nanotechnology Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran

Abstract

Background: Cetirizine is a second-generation antihistamine with anti-allergy and anti-itching properties. The topical formulation of this medicine is used in androgenic alopecia treatment. Due to the hydrophilic nature of cetirizine, its skin absorption is negligible, so to increase its absorption, various enhancers were examined to see which can be used in the design of a topical formulation.
Methods: First, the skin was exposed to enhancers, including eucalyptus, menthol, Tween 80, propylene glycol, and oleic acid, for 1 or 2 hours. Then, the permeability parameters of the cetirizine solution and the structural changes of the skin after exposure to enhancers were analyzed by differential scanning calorimetry (DSC) and Fourier-transform infrared spectroscopy (FTIR) techniques.
Results: The obtained results show that all used enhancers increased the permeability of the drug cetirizine compared to water. Various mechanisms, such as liquefaction of lipids, destruction of lipid structure, and irreversible denaturation of intracellular keratin, are involved in the increase in drug penetration caused by eucalyptus, mint, Tween 80, propylene glycol, and oleic acid.
Conclusions: The results showed that among the studied absorption enhancers, eucalyptus and Tween 80 had the strongest, and propylene glycol had the weakest absorption enhancement effect after 2- and 1-hour pre-contact, respectively.

Keywords

Main Subjects

  1. Spencer CM, Faulds D, Peters DH. Cetirizine. A reappraisal of its pharmacological properties and therapeutic use in selected allergic disorders. Drugs. 1993;46(6):1055-80. doi: 10.2165/00003495-199346060-00008.
  2. Campoli-Richards DM, Buckley MM, Fitton A. Cetirizine. A review of its pharmacological properties and clinical potential in allergic rhinitis, pollen-induced asthma, and chronic urticaria. Drugs. 1990;40(5):762-81. doi: 10.2165/00003495- 199040050-00009.
  3. Lee KY, Mooney DJ. Alginate: properties and biomedical applications. Prog Polym Sci. 2012;37(1):106-26. doi: 10.1016/j.progpolymsci.2011.06.003.
  4. Chen X, Xiang H, Yang M. Topical cetirizine for treating androgenetic alopecia: a systematic review. J Cosmet Dermatol. 2022;21(11):5519-26. doi: 10.1111/jocd.15309.
  5. Pagliara A, Testa B, Carrupt PA, Jolliet P, Morin C, Morin D, et al. Molecular properties and pharmacokinetic behavior of cetirizine, a zwitterionic H1-receptor antagonist. J Med Chem. 1998;41(6):853-63. doi: 10.1021/jm9704311.
  6. Vitorino C, Sousa J, Pais A. Overcoming the skin permeation barrier: challenges and opportunities. Curr Pharm Des. 2015;21(20):2698-712. doi: 10.2174/138161282166615042 8124053.
  7. Lever WF. Histopathology of the Skin. J. B. Lippincott & Co; 1949.
  8. Pillion DJ, Recchia J, Wang P, Marciani DJ, Kensil CR. DS- 1, a modified Quillaja saponin, enhances ocular and nasal absorption of insulin. J Pharm Sci. 1995;84(11):1276-9. doi: 10.1002/jps.2600841104.
  9. Barry BW. Novel mechanisms and devices to enable successful transdermal drug delivery. Eur J Pharm Sci. 2001;14(2):101- 14. doi: 10.1016/s0928-0987(01)00167-1.
  10. Kogan A, Garti N. Microemulsions as transdermal drug delivery vehicles. Adv Colloid Interface Sci. 2006;123- 126:369-85. doi: 10.1016/j.cis.2006.05.014.
  11. Salimi A, Mohammad Soleymani S, Mohammad Soleymani H. The use of nano-carriers in transdermal drug delivery. Jundishapur Sci Med J. 2020;19(4):435-64. doi: 10.22118/ jsmj.2020.211687.1918. [Persian].
  12. Dreher F, Walde P, Walther P, Wehrli E. Interaction of a lecithin microemulsion gel with human stratum corneum and its effect on transdermal transport. J Control Release. 1997;45(2):131- 40. doi: 10.1016/s0168-3659(96)01559-3.
  13. Williams AC, Barry BW. Penetration enhancers. Adv Drug Deliv Rev. 2012;64 Suppl:128-37. doi: 10.1016/j. addr.2012.09.032.
  14. Aboofazeli R, Zia H, Needham TE. Transdermal delivery of nicardipine: an approach to in vitro permeation enhancement. Drug Deliv. 2002;9(4):239-47. doi: 10.1080/10717540260397855.
  15. Karande P, Jain A, Ergun K, Kispersky V, Mitragotri S. Design principles of chemical penetration enhancers for transdermal drug delivery. Proc Natl Acad Sci U S A. 2005;102(13):4688- 93. doi: 10.1073/pnas.0501176102.
  16. Salimi A, Moghimipour E, Kogani P, Mohammad Soleymani S. The effect of various penetration enhancers on the octyl methoxycinnamate permeability: mechanisms of action study. Iran J Pharm Sci. 2020;16(2):87-104.
  17. Kim YC, Park JH, Ludovice PJ, Prausnitz MR. Synergistic enhancement of skin permeability by N-lauroylsarcosine and ethanol. Int J Pharm. 2008;352(1-2):129-38. doi: 10.1016/j. ijpharm.2007.10.031.
  18. Mulyaningsih S, Sporer F, Reichling J, Wink M. Antibacterial activity of essential oils from Eucalyptus and of selected components against multidrug-resistant bacterial pathogens. Pharm Biol. 2011;49(9):893-9. doi: 10.3109/13880209.2011.553625.
  19. Chey WD, Lacy BE, Cash BD, Epstein M, Shah SM. Efficacy of caraway oil/L-menthol plus usual care vs placebo plus usual care, in functional dyspepsia patients with post-prandial distress (PDS) or epigastric pain (EPS) syndromes: results from a US RCT. Gastroenterology. 2017;152(5):S307. doi: 10.1016/ s0016-5085(17)31314-8.
  20. Cheng M, Zeng G, Huang D, Yang C, Lai C, Zhang C, et al. Advantages and challenges of Tween 80 surfactant-enhanced technologies for the remediation of soils contaminated with hydrophobic organic compounds. Chem Eng J. 2017;314:98- 113. doi: 10.1016/j.cej.2016.12.135.
  21.  
  22. Sales-Campos H, de Souza PR, Peghini BC, da Silva JS, Cardoso CR. An overview of the modulatory effects of oleic acid in health and disease. Mini Rev Med Chem. 2013;13(2):201-10.
  23. De Cock RF, Allegaert K, Vanhaesebrouck S, de Hoon J, Verbesselt R, Danhof M, et al. Low but inducible contribution of renal elimination to clearance of propylene glycol in preterm and term neonates. Ther Drug Monit. 2014;36(3):278- 87. doi: 10.1097/ftd.0000000000000003.
  24. Jacob SE, Scheman A, McGowan MA. Propylene glycol. Dermatitis. 2018;29(1):3-5. doi: 10.1097/ der.0000000000000315.
  25. El Walily AF, Korany MA, El Gindy A, Bedair MF. Spectrophotometric and high-performance liquid chromatographic determination of cetirizine dihydrochloride in pharmaceutical tablets. J Pharm Biomed Anal. 1998;17(3):435-42. doi: 10.1016/s0731-7085(97)00213-6.
  26. Ermer J, Miller JH. Method Validation in Pharmaceutical Analysis: A Guide to Best Practice. John Wiley & Sons; 2006.
  27. Kunieda H, Hasegawa Y, John AC, Naito M, Muto M. Phase behaviour of polyoxyethylene hydrogenated castor oil in oil/water system. Colloids Surf A Physicochem Eng Asp. 1996;109:209-16. doi: 10.1016/0927-7757(95)03456-0.
  28. Álvarez Á, Yáñez J. Screening of gunshot residue in skin using attenuated total reflection Fourier transform infrared (ATR FT-IR) hyperspectral microscopy. Appl Spectrosc. 2020;74(4):400- 7. doi: 10.1177/0003702819892930.
  29. Raja M, Raj Muhamed R, Muthu S, Suresh M. Synthesis, spectroscopic (FT-IR, FT-Raman, NMR, UV–visible), NLO, NBO, HOMO-LUMO, Fukui function and molecular docking study of (E)-1-(5-bromo-2-hydroxybenzylidene) semicarbazide. J Mol Struct. 2017;1141:284-98. doi: 10.1016/j.molstruc.2017.03.117.
  30. Salimi A, Emam M, Mohammad Soleymani S. Increase adapalene delivery using chemical and herbal enhancers. J Cosmet Dermatol. 2021;20(9):3011-7. doi: 10.1111/ jocd.13960.
  31. Salimi A, Moghimipour E, Kashani S, Mohammad Soleymani S. The effect of various vehicles on the in vitro skin permeability of minoxidil. J Kermanshah Univ Med Sci. 2022;26(3):e128920. doi: 10.5812/jkums-128920.
  32. Salimi A, Sharif Makhmalzadeh B, Davood Baharvandi G, Mohammad Soleymani S. The effect of vegetable and volatile oils on the piroxicam skin permeability: a mechanistic study. J Kermanshah Univ Med Sci. 2022;26(2):e126619. doi: 10.5812/jkums-126619.
  33. Constantinides PP, Lancaster CM, Marcello J, Chiossone DC, Orner D, Hidalgo I, et al. Enhanced intestinal absorption of an RGD peptide from water-in-oil microemulsions of different composition and particle size. J Control Release. 1995;34(2):109-16. doi: 10.1016/0168-3659(94)00129-i.
  34. Kawakami K, Yoshikawa T, Moroto Y, Kanaoka E, Takahashi K, Nishihara Y, et al. Microemulsion formulation for enhanced absorption of poorly soluble drugs: I. Prescription design. J Control Release. 2002;81(1-2):65-74. doi: 10.1016/s0168- 3659(02)00049-4.
  35. Salimi A, Mohammad Soleymani H, Mohammad Soleymani S. Altered skin permeation of finasteride using clove oil, urea, and lyophilized powder of grape seed extract. Adv Pharm Bull. 2023;13(1):96-103. doi: 10.34172/apb.2023.010.
  36. Sapra P, Allen TM. Ligand-targeted liposomal anticancer drugs. Prog Lipid Res. 2003;42(5):439-62. doi: 10.1016/ s0163-7827(03)00032-8.
  37. Obata Y. Relation between aroma and chemical constitution. Journal of Synthetic Organic Chemistry Japan. 1959;17(2):55- 78. doi: 10.5059/yukigoseikyokaishi.17.55.
  38. Aoyagi T, Terashima O, Suzuki N, Matsui K, Nagase Y. Polymerization of benzalkonium chloride-type monomer and application to percutaneous drug absorption enhancer. J Control Release. 1990;13(1):63-71. doi: 10.1016/0168- 3659(90)90075-5.
  39. Lin SY, Duan KJ, Lin TC. Simultaneous determination of the protein conversion process in porcine stratum corneum after pretreatment with skin enhancers by a combined microscopic FT-IR/DSC system. Spectrochim Acta A Mol Biomol Spectrosc. 1996;52(12):1671-8. doi: 10.1016/0584-8539(96)01722-9.